Harbour biomed enters into a license and collaboration agreement with moderna

Cambridge, mass., rotterdam, netherlands and suzhou, china , nov. 10, 2022 /prnewswire/ -- harbour biomed (the "company", hkex: 02142) today announced that nona biosciences, a subsidiary wholly owned by the company, had entered into a license and collaboration agreement with modernatx, inc. (nasdaq: mrna), a global biotechnology company pioneering messenger rna (mrna) therapeutics and vaccines.
MRNA Ratings Summary
MRNA Quant Ranking